Viracta Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $50,693,000.
Profit Margin
| 2014 | 5.73M | -44.72M | -779.93% |
|---|---|---|---|
| 2015 | 3.06M | -36.67M | -1198.17% |
| 2016 | 2.53M | -39.74M | -1567.19% |
| 2017 | 669K | -35.45M | -5300.15% |
| 2018 | 237K | -27.76M | -11716.88% |
| 2019 | 2.07M | -23.33M | -1125.42% |
| 2020 | 120K | -19.19M | -15999.17% |
| 2021 | 0 | -203.06M | |
| 2022 | 0 | -49.77M | |
| 2023 | 0 | -51.05M |
VIRX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 120K | 2.07M | 237K | 669K | 2.53M | 3.06M | 5.73M |
Cost of revenue | 492K | 210K | 178K | 32K | 0 | 0 | 9K | 0 | 0 | 0 |
Gross profit | -492K | -210K | -178K | 88K | 2.07M | 237K | 660K | 2.53M | 3.06M | 5.73M |
Operating exp. | ||||||||||
Research and development | 33.36M | 26.26M | 23.86M | 13.46M | 15.41M | 14.61M | 21.54M | 22.88M | 23.70M | 27.66M |
Selling and marketing | 0 | 0 | 0 | 0 | 9.94M | 0 | -9K | 0 | -27K | 0 |
Total operating expenses | 50.69M | 50.58M | 25.79M | 18.81M | 25.36M | 25.94M | 35.07M | 38.99M | 42.33M | 50.77M |
Operating income | -50.69M | -50.58M | 62.50M | -18.81M | -23.28M | -25.46M | -34.41M | -36.30M | -39.30M | -41.28M |
Other income (expenses), net | -365K | 1.39M | -177.26M | -202K | -42K | -1.15M | -1.03M | -1.72M | 2.62M | 2.04M |
Income before tax | -51.05M | -49.19M | -114.76M | -19.01M | -23.33M | -26.61M | -35.45M | -38.02M | -36.67M | -43.00M |
Income tax expense | 0 | 577K | 88.3M | 182K | 514K | 1.15M | 1.39M | 1.72M | 939K | 1.71M |
Net income | -51.05M | -49.77M | -203.06M | -19.19M | -23.33M | -27.76M | -35.45M | -39.74M | -36.67M | -44.72M |
Earnings per share | ||||||||||
Basic EPS | -1.32 | -1.32 | -6.37 | -206.93 | -9.37 | -7.8 | -50.62 | -25.33 | -105.6 | -44.68 |
Diluted EPS | -1.32 | -1.32 | -6.37 | -206.93 | -9.37 | -7.8 | -50.62 | -25.33 | -105.6 | -43.62 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |